CareDx

CareDx is a company focused on providing a comprehensive suite of solutions tailored for transplant care. It offers a range of transplant lab products, including HLA typing solutions and post-transplant surveillance tools, designed to support kidney, heart, and lung transplants. The company’s services extend to noninvasive surveillance tests that help in identifying transplant injuries and ruling out rejection. CareDx also provides digital solutions, such as Ottr Organ, Ottr Cellular, and XynQAPI, which are aimed at streamlining the management of transplants. Additionally, it offers AlloCell for allogeneic cell therapy surveillance, enhancing the monitoring and care of cell transplant therapies. CareDx is committed to supporting the professional growth of healthcare providers through education, training, webinars, and patient care management resources. For patients, CareDx provides at-home blood tests and digital health applications like AlloCare, which facilitate ongoing care and monitoring. The company also collaborates with biopharmaceutical partners, offering pharma services to accelerate clinical development. Furthermore, CareDx engages in strategic partnerships and alliances with global medical institutions and biopharmaceutical companies, and supports clinical research through funding investigator-initiated trials and grants.